| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
31,327,058 | 26,005,980 | 29,009,254 | 31,450,109 | 30,936,904 |
|
Cost of Revenue
|
-8,818,131 | -8,947,477 | -8,710,543 | -9,273,423 | -8,680,490 |
|
Gross Profit
|
22,508,927 | 17,058,503 | 20,298,711 | 22,176,686 | 22,256,414 |
| Selling, General and Administrative Expenses
|
-7,616,438 | -7,288,731 | -9,741,909 | -10,330,300 | -11,510,265 |
|
Research and Development Expenses
|
-6,155,573 | -5,808,743 | -5,190,656 | -4,830,375 | -3,986,516 |
| Provision Expense/Write-Back
|
9,971 | 9,971 | -16,304 | -- | -- |
| Other Income/Expense, Operating
|
210,300 | 210,300 | 128,772 | -- | -- |
|
Operating Income/Expenses
|
-13,551,740 | -12,877,203 | -14,820,097 | -15,160,675 | -15,496,781 |
|
Total Operating Profit/Loss
|
8,957,187 | 4,181,300 | 5,478,614 | 7,016,011 | 6,759,633 |
| Total Net Finance Income/Expense
|
165,611 | 157,277 | 188,824 | -25,896 | -24,891 |
| Net Investment Income
|
257,995 | 249,150 | -174,151 | -54,196 | -15,395 |
| Irregular Income/Expenses
|
-16,472 | -16,472 | -23,398 | 32,861 | 48,065 |
|
Other Income/Expense, Non-Operating
|
-144,748 | 236,862 | 108,837 | 420,592 | 814,849 |
|
Non-Operating Income/Expenses, Total
|
262,386 | 626,817 | 100,112 | 373,361 | 822,628 |
|
Pretax Income
|
9,219,573 | 4,808,117 | 5,578,726 | 7,389,372 | 7,582,261 |
|
Provision for Income Tax
|
-1,457,057 | -931,727 | -1,239,901 | -1,316,679 | -1,350,211 |
|
Net Income from Continuing Operations
|
7,762,516 | 3,876,390 | 4,338,825 | 6,072,693 | 6,232,050 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
7,762,516 | 3,876,390 | 4,338,825 | 6,072,693 | 6,232,050 |
|
Non-Controlling/Minority Interests
|
-334,047 | 5,718 | -10,790 | -199,368 | -140,660 |
|
Net Income after Non-Controlling/Minority Interests
|
7,428,469 | 3,882,108 | 4,328,035 | 5,873,325 | 6,091,390 |
|
Net Income Available to Common Stockholders
|
7,428,469 | 3,882,108 | 4,328,035 | 5,873,325 | 6,091,390 |
|
Diluted Net Income Available to Common Stockholders
|
7,428,469 | 3,882,108 | 4,328,035 | 5,873,325 | 6,091,390 |
|
Common Dividend per Share
|
1.32 | 1.16 | 1.04 | 1.12 | 0.84 |
| Basic EPS
|
2.61 | 1.36 | 1.47 | 1.98 | 2.04 |
| Diluted EPS
|
2.60 | 1.36 | 1.47 | 1.98 | 2.04 |
|
Basic Weighted Average Shares Outstanding
|
2,851,967 | 2,855,923 | 2,934,510.2500 | 2,968,005.2500 | 2,979,301 |
|
Diluted Weighted Average Shares Outstanding
|
2,854,295 | 2,855,923 | 2,934,510.7500 | 2,968,257.7500 | 2,979,630.7500 |
|
Reported Normalized Basic EPS
|
159.60 | -- | 159.60 | 211.44 | -- |
|
Reported Normalized Diluted EPS
|
159.60 | -- | 159.60 | 211.44 | -- |
| Income Statement, Supplemental
|
12/31/2022 - 3/25/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade